IDDO’s malaria data hub, the WorldWide Antimalarial Resistance Network, has launched five themes that form a focus for its expanding research on monitoring resistance and maximising the efficacy of current and new antimalarial drugs.

Researchers at the Medicine Quality Research Group, University of Oxford and collaborators, including the Serum Institute of India, have published an innovative method to identify falsified vaccines without opening the vaccine vial.

A new study has found methaemoglobin levels during treatment for vivax malaria could be used to predict whether a patient would have recurrent malaria.

The Medicine Quality Research Group invited to present at the World Health Summit Dr Gesa Gnegel and Dr Céline Caillet were invited to present their current work during a session at the World Health Summit Berlin, Germany, on October 15.

Join IDDO and WWARN’s researchers at this year’s American Society of Tropical Medicine & Hygiene (ASTMH) in where we will be presenting on Visceral Leishmaniasis, malaria, COVID-19 and across symposia, oral presentations and posters.

Experts from across Europe joined forces to discuss research on substandard and falsified medical products and how to translate the evidence into policy and implementation.

A new study which will help inform World Health Organization guidelines for treating children with Plasmodium vivax malaria has found that giving children higher doses of primaquine substantially reduced recurrences of malaria.

Collaborators of a multi-country project aimed at better understanding the impact, origin and trade routes of falsified medical products gathered to share updates and make final year plans.

IDDO and the Global Research on Antimicrobial Resistance (GRAM) Project are delighted to announce the first antimicrobial resistance (AMR) dataset is now available to reuse for further research.

A new systematic review, published in the American Journal of Tropical Medicine & Hygiene, summarises the heterogeneity in design and analysis of clinical trials for visceral leishmaniasis (VL) – information which can potentially help improve future trial designs.

Nominations for new IDDO Data Access Committee (DAC) members are now open. Please nominate individuals with expertise in Chagas Disease, Antimicrobial Resistance or visceral leishmaniasis to dataaccess@iddo.org.

A new review summarises existing evidence gaps regarding when blood transfusions should be carried out for visceral leishmaniasis patients. The review is published in Transactions of the Royal Society of Tropical Medicine and Hygiene.

Experts from across the globe joined forces to discuss how screening technologies can be improved so they can be more widely used to detect substandard and falsified medical products.

An updated systematic search and review of published information from over 4,000 malaria samples has identified areas in central, eastern and north-eastern India where treatment-resistant malaria parasites could be more prevalent.

New work from the Medicine Quality Group at IDDO and MORU pilots the use of stable isotope mass spectrometry to estimate where falsified antimalarials and their components come from. The study, published in Scientific Reports, is a collaboration between the Medicine Quality Research Group, LOMWRU, a...